TISSUE DONATION IS CRITICAL TO FIND TREATMENTS! Click here to learn more.
Below is a continuously updated list of active clinical trials for EHE. Additional details and contacts for each study are available at the ClinicalTrials.gov identifier. To learn more about these studies, contact our research team, and to learn more about the phases of clinical trials visit cancer.org.
A clinical trial is a type of research that studies a test, treatment, or other intervention according to a research plan. This may include drugs that are not yet approved by the FDA, drugs that are already approved and are being investigated for new or different purposes, comparisons of drugs, devices or procedures, or other types of interventions.
Phase 1 clinical trials (studies) are the first step in testing new drug candidates in humans. These studies are done primarily to test safety, side effects, and the best dose of a potential new treatment. Some study participants may benefit from the drug candidate being tested; however, disease response is not the primary purpose of phase 1 studies.
Observational studies are another type of research study where doctors assess the health outcomes of participants. These studies are done as a part of routine care and help researchers understand the effects of a treatment, procedure, or other lifestyle change.
When considering participation in a clinical trial or any other research we urge you to consult your physician or other qualified medical resource as well as the person who is conducting the research study to answer any questions you have. The information provided here is for information only and is not intended as medical advice or a recommendation.
Greg Cote, MD, PhD, medical oncologist, and early-stage clinical trialist from Mass General Cancer Center joined us on July 27, 2024, to provide an in-depth look at the drug development process and discuss the landscape of clinical trials that include patients with epithelioid hemangioendothelioma (EHE).
Get email alerts about the latest treatments, research advances, and opportunities to get involved.